Sofia Gardella swimming the favorite pasture, driving on her bike and spends time with her friends. Yet today, 11, would not enjoy these simple pleasures if it had not been a life -saving stem cell transplantation nine years ago.
Her parents, Claire and Fabio, were destroyed to hear that their baby daughter had a rare and life -threatening genetic disorder.
Een verloskundige zag kleine sporen op de armen en benen van Baby Sofia, ‘een beetje zoals moedervlekken, maar Purple’, zegt Claire, 43, een ergotherapeut, die in Mansfield woont, Nottinghamshire, Nottinghamshire, met Fabio, ook 43, die in de verkoop werkt, en hun dochters, en een extreem lage niveau van een extreem lage niveau van een extreem lage niveau van een extreem Low level of an extremely low level. Clot Correct) – And this was caused by a condition called congenital amegakaryocytic thrombocytopenia (camt), which meant that her body produced too few bone marrow cells that were needed to make platelets.
CamT can be life threatening because patients run the risk of bleeding spontaneously, even due to a small knock. The condition can also claim to influence other types of blood cells, including the white blood cells needed to combat infections – which means that even ‘mild’ diseases can become deadly.
“It was a total shock, especially because Sofia didn’t look bad at all,” says Claire.
Sofia needed urgent chemotherapy to get rid of her defective bone marrow (the spongy tissue in the bones that plays a crucial role in producing blood cells), followed by a stem cell transplantation of a donor to encourage the growth of a healthy bone marrow.
Without this treatment, Sofia’s bone marrow would stop functioning by the time she was five – which could be fatal. “We were told that there was a 90 percent chance that the treatment was successful – but we were very afraid that they could not find a donor,” says Claire.
When family members turned out not to be a sufficiently good fabric competition, doctors searched national and international registers to find another suitable donor.
Sofia, 11, with her mother Claire in the new Anthony Nolan Cell Collection Center in Nottingham
It was the stem cell -in love with Anthony Nolan, who hit proverbial gold and found a match in Germany: a woman in forty.
But the family still had to wait a ‘painful’ year for doctors to see Sofia as ready for a stem cell transplantation at the age of two as a stem cell transplantation.
“The following year was full of fear,” says Claire. “Sofia was closely monitored and we didn’t know if she would even survive the transplant.” Claire remembers her excitement when the transplant day arrived in 2016 and she saw the courier arriving in the hospital with the donated stem cells for Sofia.
“I saw the courier with the box,” she says. “When the nurse brought and opened the box in the room of Sofia, there was something like a bag of blood inside – we told Sofia that it was a bag of magical cells.”
The treatment has been transforming for Sofia. But others are not so lucky – because while the demand for stem cell fluctuates donations, the supply is not keeping track of.
Tragically enough, some people die – and not just because of a lack of suitable donors. In fact, 2.3 million people are in the British register to be stem cells.
The problem is that, as soon as a competition was identified, a donor would be invited to go to a hospital or independent center with specialized equipment to make the donation – but there are not enough of this to keep the question. Only one in five donors in the British register could donate on the date requested in 2022-23 for capacity issues, according to data collected by Anthony Nolan.
“Sometimes a gathering center may not be able to offer a lock for two or three months because they have already been completely booked,” says Dr. Lilian Hook, director of Cel, Afheresis and gene therapies at NHS blood and transplantation.
Such a waiting time can be catastrophic for the patient who needs the transplant. “Often these are very sick people – and if they have to wait a few months more, they can get too ill to undergo a transplant,” says Dr. Hook.
“Unfortunately, patients sometimes deteriorate and can even die while waiting for a stem cell transplant,” Dr. adds. Chloe Anthias, a hematologist and stem cell transplant adviser in the Royal Marsden Hospital in London. ‘All collection centers are in capacity and we need more slots. It is almost on crisis point. ‘
The lack of facilities, in combination with a need for young donors with high -quality stem cells, means that 70 percent of the stem cell transplants in the UK comprise cells.
“Many come from Germany, where there is an extensive stem cell register and where donors often have a good tissue match for British patients,” says Dr. Hook. But this is complicated to organize and ‘expensive’, she says.
The demand for stem cell transplants has risen by a third in ten years – from around 3,800 in 2013 to just under 5,000 in 2023 (the last year for which figures are available).
This is partly due to improvements, which means that the procedure is now suitable for more patients, but also because the use of stem cells is enormously expanded.
Traditionally, stem cell transplants were used to treat blood cancer, such as leukemia and myeloma. But they are now also used for blood disorders, such as sickle cell anemia (where abnormally formed red blood cells form that can block blood vessels) and rarer disorders, such as camt for which there were few treatments before, Dr. Anthias.
Stem cells are increasingly being modified for cancer and gene therapies. Such a treatment, Car T cell therapy, includes harvesting and reprogramming a patient’s own blood cells to combat certain blood cancer.
“However, all these treatments require cell collection services,” says Dr. Anthias, who is a donor adviser at Anthony Nolan.
The Omaze Cheshire house can be won in the draw that closes at midnight on July 27
Giving stem cells is not as easy as giving blood. The donor receives injections of a hormone to stimulate the release of stem cells in the blood. Blood is then pulled out of one arm with the help of a special machine, which separates and collects the stem cells – and returns the rest of the blood to the other arm. In a minority of cases, stem cells are removed from bone marrow in a procedure that requires a general anesthesia.
It is not a delay to bring them to the patient, says Dr. Hook. “The biggest problem lies in finding a suitable donor and collecting the cells.” But the situation seems to improve, thanks to the new Anthony Nolan Cell Collection Center, which will open this summer in Nottingham.
The center, which will benefit from funds collected by the current Omaze Cheshire House Draw, is the first in the UK that is fully devoted to cell collection for patients who need stem cell transplants and gene therapies. Omaze sells tickets for a draw to win a glamorous house somewhere in the country – earlier draws have raised money for other charity institutions for healthcare.
The new Anthony Nolan Cell Collection Center, in collaboration with Nottingham Hospitals NHS Trust, wants to offer 1,300 new cell collection slots per year and will also research new cell therapies.
The exact amount that the center receives depends on how much the draw, but Anthony Nolan receives at least £ 1 million – enough to run the center for six months.
In the meantime, NHS blood and transplant also expands its cell collection capacity and tries to recruit more donors.
Men younger than 30 are mainly sought as donors because men, generally larger, produce more stem cells – and the younger the donor, the more effective they are. Donors with mixed and ethnic minority grounds are also necessary because it can be more difficult to find a fabric competition for them, says Dr. Hook.
Stem cell transplants are not without risks. Sofia developed Transplant-Versus-Host disease, in which the donated cells attack a patient’s own cells after her first transplant in 2016. She needed steroids to combat it, causing liquid in her brain, which influenced her memory. She needed a second stem cell transplant in 2018 because her platelet levels started to fall again.
“At one point I wondered if she would ever get better,” says Claire. But now the platelet levels of Sofia are normal. She needs extra help at school and takes penicillin to protect her against infections – but the family counts their blessings.
“I’m just happy that I can finally do normal things,” says Sofia.
Claire adds: “We are so grateful for the transplant of Sofia – it’s great to know that a new center can help so many patients and families like ours.”
Submissions for the Omaze -similar game in Cheshire Close at midnight on July 27 to visit Omaze.co.uk.
#latest #Omaze #Cheshire #House #Draw #advantage #thousands #life #saving #stem #cell #transplants